Viewing Study NCT05276492

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-02-03 @ 8:07 PM
Study NCT ID: NCT05276492
Status: TERMINATED
Last Update Posted: 2025-10-03
First Post: 2022-03-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.
Sponsor: University of Chicago
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
None Prostate Adenocarcinoma View
None Prostate Neoplasm View
None Prostate Cancer Metastatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate cancer View
None prostate adenocarcinoma View